High affinity serotonin binding sites in human brain: a comparison of cerebral cortex and basal ganglia

The high-affinity binding of3H-serotonin and3H-DP-AT was studied in membrane preparations and tissue sections of cerebral cortex and basal ganglia of human brain. In tissue sections,3H-serotonin bound to sites present at high density in the cerebral cortex, hippocampus and basal ganglia.3HDPAT bound predominantly to the outer layers of the cerebral cortex and the hippocampus, no significant binding was observed in the basal ganglia. In cortical membranes3H-serotonin bound to a heterogeneous population of sites, one of which was similar to a binding site labelled by3H-DPAT (the putative 5HT-1A receptor).3H-serotonin binding to membranes prepared from the putamen displayed low affinity for DPAT, mesulergine and spiperone, RU 24969 was considerably less potent than serotonin itself. This3H-serotonin binding site does not have the properties of those sites described in rodent brain (5 HT-1 A, 5 HT-1 B, and 5 HT-1 C), and may represent a novel serotoninergic binding site.

[1]  J. Palacios,et al.  Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites , 1986, Brain Research.

[2]  D. Reiss,et al.  Characterization of 5-hydroxytryptamine receptors in rat stomach fundus. , 1985, The Journal of pharmacology and experimental therapeutics.

[3]  Distribution of serotonin-1A receptors in the monkey and the postmortem human hippocampal region. A quantitative autoradiographic study using the selective agonist [3H]8-OH-DPAT , 1986, Neuroscience Letters.

[4]  L. Snyder,et al.  Characterization and localization of serotonin receptors in human brain postmortem , 1986, Brain Research.

[5]  J. Deniau,et al.  High-affinity binding of (3H) 5-hydroxytryptamine to brain synaptosomal membranes: comparison with (3H) lysergic acid diethylamide binding. , 1978, Molecular pharmacology.

[6]  J. Fields,et al.  Neurotransmitter receptor alterations in Parkinson's disease. , 1977, Life sciences.

[7]  J. Glowinski,et al.  Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT , 1983, Nature.

[8]  A. Cross Interactions of [3H]LSD with serotonin receptors in human brain. , 1982, European journal of pharmacology.

[9]  J. Palacios,et al.  Serotonin receptors in the human brain—III. Autoradiographic mapping of serotonin-1 receptors , 1987, Neuroscience.

[10]  J. Palacios,et al.  Serotonin receptors in the human brain. I. Characterization and autoradiographic localization of 5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sites , 1986, Brain Research.

[11]  D. Clarke,et al.  An inhibitory prejunctional 5-HT1-like receptor in the isolated perfused rat kidney , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

[12]  S H Snyder,et al.  Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol. , 1979, Molecular pharmacology.

[13]  D. Hoyer,et al.  Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin. , 1985, European journal of pharmacology.

[14]  H. Yamamura,et al.  Discrimination of Multiple [3H]5‐Hydroxytryptamine Binding Sites by the Neuroleptic Spiperone in Rat Brain , 1981, Journal of neurochemistry.

[15]  S. Peroutka,et al.  Characterization of a novel 3H-5-hydroxytryptamine binding site subtype in bovine brain membranes , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[16]  D. Middlemiss Functional Correlates of the Subtypes of the 5-ht1 Recognition Site , 1986 .

[17]  S. Peroutka,et al.  Pharmacological Differentiation and Characterization of 5‐HT1A, 5‐HT1B, and 5‐HT1C Binding Sites in Rat Frontal Cortex , 1986, Journal of neurochemistry.

[18]  S. Peroutka,et al.  Species variations in RU 24969 interactions with non-5-HT1A binding sites. , 1986, European journal of pharmacology.

[19]  J. Palacios,et al.  The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site. , 1984, European journal of pharmacology.

[20]  D. Middlemiss,et al.  8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates between subtypes of the 5-HT1 recognition site. , 1983, European journal of pharmacology.

[21]  E. Schlicker,et al.  Serotonin release in human cerebral cortex and its modulation via serotonin receptors , 1985, Brain Research.

[22]  S. Snyder,et al.  Serotonin and lysergic acid diethylamide binding in rat brain membranes: relationship to postsynaptic serotonin receptors. , 1976, Molecular pharmacology.

[23]  M. De Vivo,et al.  Characterization of the 5-hydroxytryptamine1a receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes. , 1986, The Journal of pharmacology and experimental therapeutics.

[24]  G. Reynolds,et al.  Brain serotonin receptors in Huntington's disease , 1986, Neurochemistry International.

[25]  E. Schlicker,et al.  Autoreceptor-mediated inhibition of 3H-5-hydroxytryptamine release from rat brain cortex slices by analogues of 5-hydroxytryptamine. , 1983, Life sciences.

[26]  J. Palacios,et al.  [3H]Spiperone binding sites in brain: autoradiographic localization of multiple receptors , 1981, Brain Research.

[27]  E. Schlicker,et al.  Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.